Skip NavigationSkip to Content

Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization

  1. Author:
    Pack, S. D.
    Zbar, B.
    Pak, E.
    Ault, D. O.
    Humphrey, J. S.
    Pham, T.
    Hurley, K.
    Weil, R. J.
    Park, W. S.
    Kuzmin, I.
    Stolle, C.
    Glenn, G.
    Liotta, L. A.
    Lerman, M. I.
    Klausner, R. D.
    Linehan, W. M.
    Zhuang, Z. P.
  2. Author Address

    Pak E NINDS, Surg Neurol Branch, NIH Bldg 10,Room 5D37,9000 Rockville Pike Bethesda, MD 20892 USA NINDS, Surg Neurol Branch, NIH Bethesda, MD 20892 USA NCI, Pathol Lab, NIH Bethesda, MD 20892 USA NCI, Urol Oncol Branch, NIH Bethesda, MD 20892 USA NCI, Genet Epidemiol Branch, NIH Bethesda, MD 20892 USA NCI, Off Director, NIH Bethesda, MD 20892 USA Sci Applicat Int Corp, Dept Pathol, Intramural Res Support Program Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, Immunobiol Lab Frederick, MD 21702 USA NINDS, Surg Neurol Branch, NIH Bethesda, MD 20892 USA Univ Penn, Genet Diagnost Lab Philadelphia, PA 19104 USA
    1. Year: 1999
  1. Journal: Cancer Research
    1. 59
    2. 21
    3. Pages: 5560-5564
  2. Type of Article: Article
  1. Abstract:

    von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al, J. Am. Med. Assoc., 273: 564-570, 1995; E, A. Maher and W. G. Kaelin, Jr., Medicine (Baltimore), 76: 381-391, 1997; W. M. Linehan and R. D. Klausner, In: B. Vogelstein and K. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 455-473, McGraw-Hill, 1998]. The VHL gene was localized to chromosome 3p25-26 and cloned [F. Latif et al, Science (Washington DC), 260: 1317-1320, 1993]. Germline mutations in the VHL gene have been detected in the majority of VHL kindreds. The reported frequency of detection of VHL germline mutations has varied from 39 to 80% (J. M. Whaley et at, Am. J, Hum. Genet., 55: 1092-1102, 1994; Clinical Research Group for Japan, Hum. Mel. GEnet,, 4: 2233-2237, 1995; F. Chen et at, Hum. Mutat., 5: 66-75, 1995; E. R. Maher et at, J. Med. Genet., 33: 328-332, 1996; B. Zbar, Cancer Surv., 25: 219-232, 1995). Recently a quantitative Southern blotting procedure was found to improve this frequency (C. Stolle et al., Hum. Mutat., 12: 417-423, 1998). In the present study, we report the use of fluorescence in situ hybridization (FISH) as a method to detect and characterize VHL germline deletions. We reexamined a group of VHL patients shown previously by single-strand conformation and sequencing. analysis not to harbor point mutations in the VHL locus. We found constitutional deletions in 29 of 30 VHL patients In this group using cosmid and PI probes that cover the VHL locus. We then tested six phenotypically normal offspring from four of these VHL families: two were found to carry the deletion and the other four were deletion-free. In addition, germline mosaicism of the VHL gene was identified in one family. In sum, FISH was found to be a simple and reliable method to detect VHL germline deletions and practically useful in cases where other methods of screening have failed to detect a VHL gene abnormality. [References: 21]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel